75 related articles for article (PubMed ID: 12425820)
21. Transformation assays for HPV oncoproteins.
Massimi P; Banks L
Methods Mol Med; 2005; 119():381-95. PubMed ID: 16350412
[TBL] [Abstract][Full Text] [Related]
22. [Radiation sensitizing effect of anti HPV16E6-ribozyme on cervical carcinoma cell line].
Rao ZG; Zhang JR; Zheng YF; Zhou H; Qu LH
Ai Zheng; 2002 Feb; 21(2):149-52. PubMed ID: 12479064
[TBL] [Abstract][Full Text] [Related]
23. Expression of S100P gene in cervical carcinoma cells is independent of E7 human papillomavirus oncogene.
Jakubícková L; Baráthová M; Pastoreková S; Pastorek J; Gibadulinová A
Acta Virol; 2005; 49(2):133-7. PubMed ID: 16047742
[TBL] [Abstract][Full Text] [Related]
24. Comparative analysis of cervical cancer in women and in a human papillomavirus-transgenic mouse model: identification of minichromosome maintenance protein 7 as an informative biomarker for human cervical cancer.
Brake T; Connor JP; Petereit DG; Lambert PF
Cancer Res; 2003 Dec; 63(23):8173-80. PubMed ID: 14678972
[TBL] [Abstract][Full Text] [Related]
25. Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer.
Jonson AL; Rogers LM; Ramakrishnan S; Downs LS
Gynecol Oncol; 2008 Nov; 111(2):356-64. PubMed ID: 18755502
[TBL] [Abstract][Full Text] [Related]
26. High-risk human papillomavirus E7 oncoprotein detection in cervical squamous cell carcinoma.
Ressler S; Scheiden R; Dreier K; Laich A; Müller-Holzner E; Pircher H; Morandell D; Stein I; Viertler HP; Santer FR; Widschwendter A; Even J; Jansen-Dürr P; Capesius C; Zwerschke W
Clin Cancer Res; 2007 Dec; 13(23):7067-72. PubMed ID: 18056184
[TBL] [Abstract][Full Text] [Related]
27. [Malignant transformation of the immortalized esophageal epithelial cells].
Shen Z; Shen J; Cai W; Chen J; Zeng Y
Zhonghua Zhong Liu Za Zhi; 2002 Mar; 24(2):107-9. PubMed ID: 12015026
[TBL] [Abstract][Full Text] [Related]
28. New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer.
Yamato K; Yamada T; Kizaki M; Ui-Tei K; Natori Y; Fujino M; Nishihara T; Ikeda Y; Nasu Y; Saigo K; Yoshinouchi M
Cancer Gene Ther; 2008 Mar; 15(3):140-53. PubMed ID: 18157144
[TBL] [Abstract][Full Text] [Related]
29. A mouse fibroblast cell model to study human papillomavirus-associated tumorigenesis.
Hernández P; Merino N; Lopez-Ocejo O; Araña MJ
Biochem Biophys Res Commun; 2000 Apr; 270(1):119-24. PubMed ID: 10733914
[TBL] [Abstract][Full Text] [Related]
30. [Establishment of human immortalized oral epithelial cell line HIO615 induced by HPV16 E6 and E7].
Zhang Z; Sdek P; Cao J; Zhou X; Chen W; Li Q
Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 Jan; 37(1):12-4. PubMed ID: 11955351
[TBL] [Abstract][Full Text] [Related]
31. [Inhibitory effect of bladder cancer related protein gene on HeLa cell proliferation].
Zuo ZH; Zhao M; Liu J; Wei Y; Wu XX
Ai Zheng; 2006 Jul; 25(7):811-7. PubMed ID: 16831269
[TBL] [Abstract][Full Text] [Related]
32. [The inhibitory effects of siRNA expression vector on the expression of human papillomavirus E6 gene].
Li DK; Peng ZL; Niu XY; Wang DQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 May; 36(3):331-3. PubMed ID: 15931860
[TBL] [Abstract][Full Text] [Related]
33. [Reversal effect of antisense RNA targeting human papillomavirus 16 (HPV16) E6E7 on malignancy of human cervical cancer cell line SiHa].
Sima N; Wang W; Xu Q; Tian X; Luo AY; Lu YP; Wang SX; Ma D
Ai Zheng; 2007 Jan; 26(1):26-31. PubMed ID: 17222363
[TBL] [Abstract][Full Text] [Related]
34. [Inhibitory effect of RNA interference on expression of HPV16 E6 oncogene in cervical cancer cell line CaSki].
Niu XY; Peng ZL; Wang H
Ai Zheng; 2004 Nov; 23(11):1257-62. PubMed ID: 15522169
[TBL] [Abstract][Full Text] [Related]
35. The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells.
Jeong Seo E; Jung Kim H; Jae Lee C; Tae Kang H; Seong Hwang E
Gynecol Oncol; 2004 Jul; 94(1):40-7. PubMed ID: 15262117
[TBL] [Abstract][Full Text] [Related]
36. The pro-angiogenic factors stimulated by human papillomavirus type 16 E6 and E7 protein in C33A and human fibroblasts.
Xi L; Wang S; Wang C; Xu Q; Li P; Tian X; Wu P; Wang W; Deng D; Zhou J; Ma D
Oncol Rep; 2009 Jan; 21(1):25-31. PubMed ID: 19082439
[TBL] [Abstract][Full Text] [Related]
37. HPV16 E6-mediated stabilization of ErbB2 in neoplastic transformation of human cervical keratinocytes.
Narisawa-Saito M; Handa K; Yugawa T; Ohno S; Fujita M; Kiyono T
Oncogene; 2007 May; 26(21):2988-96. PubMed ID: 17146442
[TBL] [Abstract][Full Text] [Related]
38. [Experimental study of dually targeting gene therapy system for pituitary adenomas].
Ma CY; Lu YC; Shi JX; Ren CC; Zhu JD; Gu JR
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(4):262-6. PubMed ID: 15854489
[TBL] [Abstract][Full Text] [Related]
39. Both E7 and CpG-oligodeoxynucleotide are required for protective immunity against challenge with human papillomavirus 16 (E6/E7) immortalized tumor cells: involvement of CD4+ and CD8+ T cells in protection.
Kim TY; Myoung HJ; Kim JH; Moon IS; Kim TG; Ahn WS; Sin JI
Cancer Res; 2002 Dec; 62(24):7234-40. PubMed ID: 12499264
[TBL] [Abstract][Full Text] [Related]
40. [Expression of the human papillomavirus type 16L/E7 fusion protein in E. coli and observation of its immunogenicity in mice].
Tian HW; Ye ZM; Lu ZH; Jao R; Bian T; Zhao L; Ruan L
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):33-7. PubMed ID: 16816859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]